Science News
from research organizations

Natural immunity may lead fight against liver disease

Date:
October 27, 2015
Source:
University of Adelaide
Summary:
Researchers have uncovered the role played by a family of genes, which can suppress hepatitis C virus (HCV) infection within the liver. The findings shed light on the activity of these genes and how they produce a natural immune response to the virus.
Share:
FULL STORY

University of Adelaide researchers have uncovered the role played by a family of genes, which can suppress hepatitis C virus (HCV) infection within the liver.

The findings, published in the Journal of Biological Chemistry, shed light on the activity of these genes and how they produce a natural immune response to the virus.

HCV is a major health problem in Australia, with approximately 233,000 Australians having the disease that is transmitted through contaminated blood. Unchecked HCV infection can lead to chronic disease and liver cancer, and both diseases are increasing in frequency.

The researchers have shown for the first time that antiviral proteins (the IFITM proteins) produced through the natural immune response block the entry of the hepatitis C virus into the cell.

"We now have a good idea of what the IFITM proteins do in liver cells and how they act to suppress hepatitis C infection," says Associate Professor Michael Beard, Head of the Viral Pathogenesis Laboratory in the University's School of Biological Science.

"This improved understanding of the host response to HCV infection, and the HCV entry process, will provide new direction for the development of therapeutic treatments to either heighten this natural response, or generate mimics to target the virus specifically."

The IFITM1, IFITM2 and IFITM3 proteins have been shown in laboratory settings previously to have anti-viral action against a number of different viruses, including HCV. But to date the actual role of the proteins in suppressing HCV infection has remained a mystery.

Associate Professor Beard and PhD student Sumudu Narayana studied the impact of the proteins on HCV infection in liver cells.

"Sumudu has shown that liver cells that express high levels of the IFITM proteins are resistant to infection with the hepatitis C virus by blocking entry of the virus into the cells," Associate Professor Beard says.

"Our research team demonstrated specific interactions between the proteins and the HCV entry process within the cells. It appears that the proteins act together in a specific way to target the virus.

"This now points the way forward to develop ways of enhancing these mechanisms to prevent the virus from setting up infection."


Story Source:

Materials provided by University of Adelaide. Note: Content may be edited for style and length.


Journal Reference:

  1. Sumudu K. Narayana, Karla J. Helbig, Erin M. McCartney, Nicholas S. Eyre, Rowena A. Bull, Auda Eltahla, Andrew R. Lloyd, Michael R. Beard. The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry. Journal of Biological Chemistry, 2015; 290 (43): 25946 DOI: 10.1074/jbc.M115.657346

Cite This Page:

University of Adelaide. "Natural immunity may lead fight against liver disease." ScienceDaily. ScienceDaily, 27 October 2015. <www.sciencedaily.com/releases/2015/10/151027082701.htm>.
University of Adelaide. (2015, October 27). Natural immunity may lead fight against liver disease. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2015/10/151027082701.htm
University of Adelaide. "Natural immunity may lead fight against liver disease." ScienceDaily. www.sciencedaily.com/releases/2015/10/151027082701.htm (accessed May 23, 2017).

RELATED STORIES